Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2005
07/28/2005US20050164165 Probe specific identification/classification of hepatitis c variants; genomics; reverse transcription and viral genotyping
07/28/2005US20050164162 Methods for multiple parameters screening and evolution of cells to produce small molecules with multiple functionalities
07/28/2005US20050164161 Electrical field stimulation of eukaryotic cells
07/28/2005US20050163804 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses
07/28/2005US20050163795 IHNV G protein for immune stimulation
07/28/2005US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
07/28/2005US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family
07/28/2005US20050163754 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
07/28/2005US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
07/28/2005US20050161323 Biosensor
07/28/2005EP1573636A3 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
07/28/2005DE10361137A1 Mikroarray, Kit und Verfahren zum Validieren und/oder Kalibrieren eines Systems von Hybridisierungsexperimenten Microarray kit and method for validating and / or calibrating a system of hybridization experiments
07/28/2005DE10360956A1 Use of carnosine metabolism-associated genes, for determining genetic predisposition/susceptibility to diabetic nephropathy
07/28/2005DE10359716A1 Trockenchemischer Test Dry Chemical test
07/28/2005DE10338123B3 Verfahren zum Nachweis von Bakterien der Gattung Legionella Method for detecting bacteria of the genus Legionella
07/28/2005DE102004062281A1 Producing a microarray of spots e.g. for use on a biochip, comprises applying a solution of a polymer and special molecules and then solidifying the polymer, especially by a non-radical method
07/28/2005DE102004045131A1 Korrekturverfahren für die Lichtmengenverteilung und Biochipleser Correction method for the amount of light distribution and biochip reader
07/28/2005DE10147020B4 Neue Telomerase-immoralisierte Zelllinien New telomerase immoralisierte cell lines
07/28/2005CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
07/28/2005CA2553995A1 Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
07/28/2005CA2553609A1 Methods and compositions for modulating a steroid receptor
07/28/2005CA2553303A1 Human hepatic progenitor cells and methods of use thereof
07/28/2005CA2553172A1 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation
07/28/2005CA2552658A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
07/28/2005CA2551677A1 Methods of assessing a tissue inflammatory response using expression profiles of endothelial cells
07/28/2005CA2551462A1 Methods for nucleic acid isolation and kits using solid phase material
07/28/2005CA2551453A1 Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
07/28/2005CA2551156A1 Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent
07/27/2005WO2006131783A2 Polynucleotides, polypeptides, and diagnosing lung cancer
07/27/2005EP1557663A1 Measuring instrument provided with sold component concentrating means
07/27/2005EP1557662A1 Determination method for automatically identifying analyte liquid and standard solution for biosensor
07/27/2005EP1557475A1 Storage of genetic information
07/27/2005EP1557474A1 Method for determination of protein modifying or demodifying activity and suitable materials therefor
07/27/2005EP1557473A1 REAGENT COMPOSITION FOR DETECTING beta-LACTAMASE, DETECTION KIT AND DETECTION METHOD
07/27/2005EP1557462A2 Transplant acceptance inducing cells of monocytic origin and their preparation and use
07/27/2005EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues
07/27/2005EP1557178A1 Use of sglt homolog
07/27/2005EP1557174A1 Composition containing eosinophil cationic protein
07/27/2005EP1556703A2 Inhibitors of src kinase for use in alzheimer's disease
07/27/2005EP1556697A1 Means and methods for diagnosing a treponema infection
07/27/2005EP1556695A2 Analytical platform and identification method with analytes, which are to be identified in a sample optionally after fractionation and which serve as immobilized specific binding partners
07/27/2005EP1556692A2 A method of screening for disorders of glucose metabolism
07/27/2005EP1556691A2 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity
07/27/2005EP1556689A2 Biosensor having hematocrit and oxygen biases
07/27/2005EP1556688A2 Systems and methods for the detection of short and long samples
07/27/2005EP1556682A2 IP sb 3 /sb PROTEIN BINDING ASSAY
07/27/2005EP1556521A2 Combined exponential and linear amplification
07/27/2005EP1556520A2 Qualitative differential screening for the detection of rna splice sites
07/27/2005EP1556519A1 Assay for imidazolinone resistance mutations in brassica species
07/27/2005EP1556518A2 Genes and polypeptides relating to human pancreatic cancers
07/27/2005EP1556517A1 Improved methods for generating multiple rna copies
07/27/2005EP1556516A2 HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
07/27/2005EP1556515A1 Methods for assessing efficacy of chemotherapeutic agents
07/27/2005EP1556514A2 Method for analyzing a complex biological state of a biosystem and support for its direct interpretation
07/27/2005EP1556513A2 Compositions and methods for treating human papillomavirus-mediated disease
07/27/2005EP1556511A2 Reverse transcription on microarrays
07/27/2005EP1556510A2 Oligonucleotide analogues for detecting and analyzing nucleic acids
07/27/2005EP1556507A2 Analytical chip for the detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon
07/27/2005EP1556506A1 Molecular arrays and single molecule detection
07/27/2005EP1556505A1 Modulation of s6 kinase activity for the treatment of obestiy
07/27/2005EP1556504A2 Protozoan rhomboid proteins
07/27/2005EP1556503A2 Raised surface assay plate
07/27/2005EP1556502A2 Assays to detect or quantify bacterial or viral pathogens and contaminants
07/27/2005EP1556501A1 Transdermal assay with magnetic clamp
07/27/2005EP1556483A1 CRYSTAL STRUCTURE OF i STAPHYLOCOCCUS /i UNDECAPRENYL PYROPHOSPHATE SYNTHASE AND USES THEREOF
07/27/2005EP1556480A2 Method for isolating and culturing unculturable microorganisms
07/27/2005EP1556405A2 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease
07/27/2005EP1556401A2 22 human secreted proteins
07/27/2005EP1556325A1 Anthraquinone quencher dyes, their methods of preparation and use
07/27/2005EP1556162A1 Multicomponent protein microarrays
07/27/2005EP1556154A1 A filter device integrating sampled volume control
07/27/2005EP1556152A1 A reception head for a filter unit
07/27/2005EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
07/27/2005EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
07/27/2005EP1555874A2 Gene regulation with aptamer and modulator complexes for gene therapy
07/27/2005EP1483371A4 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
07/27/2005EP1430142A4 Positive response biosensors and other sensors
07/27/2005EP1425548A4 Microcantilever apparatus and methods for detection of enzymes
07/27/2005EP1412537A4 Cardiotoxin molecular toxicology modeling
07/27/2005EP1315966A4 Method of monitoring the effect of cathepsin s inhibitors
07/27/2005EP1287014A4 Enhanced protein thermostability and temperature resistance
07/27/2005EP1283878B1 Receptor-based interaction trap
07/27/2005EP1253364B1 Ultralow expansion brake rubber hose and its production method
07/27/2005EP1210459A4 Sampling system
07/27/2005EP1144674A4 Optimized high-throughput analytical system
07/27/2005EP1086240A4 Methods for testing biological network models
07/27/2005EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods
07/27/2005EP0977848B1 Human theta subunit of the gaba-a receptor
07/27/2005EP0438512B2 Process for analysing length polymorphisms in dna domains
07/27/2005CN1646917A Method of identifying transmembrane protein-interacting compounds
07/27/2005CN1646908A Multi-functional microarrays and methods
07/27/2005CN1646906A Disruption of the REDK gene
07/27/2005CN1646706A Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
07/27/2005CN1646705A Amplification-hybridisation method for detecting and typing human papillomavirus
07/27/2005CN1646704A Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
07/27/2005CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/27/2005CN1646701A Method and test kit for demonstrating genetic identity
07/27/2005CN1646700A Methods for determining the response of cells to VEGF and uses thereof
07/27/2005CN1646699A Determining the risk of caries in a patient
07/27/2005CN1646698A Method of estimating elimination of microorganisms and apparatus for estimating elimination of microorganisms